Early Reversal of Pediatric-Neonatal Septic Shock by Community Physicians Is Associated With Improved Outcome

Author:

Han Yong Y.12,Carcillo Joseph A.132,Dragotta Michelle A.2,Bills Debra M.2,Watson R. Scott132,Westerman Mark E.2,Orr Richard A.132

Affiliation:

1. Departments of Critical Care Medicine

2. Department of Critical Care Medicine/Transport, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania

3. Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Abstract

Objective. Experimental and clinical studies of septic shock support the concept that early resuscitation with fluid and inotropic therapies improves survival in a time-dependent manner. The new American College of Critical Care Medicine-Pediatric Advanced Life Support (ACCM-PALS) Guidelines for hemodynamic support of newborns and children in septic shock recommend this therapeutic approach. The objective of this study was to determine whether early septic shock reversal and use of resuscitation practice consistent with the new ACCM-PALS Guidelines by community physicians is associated with improved outcome. Methods. A 9-year (January 1993–December 2001) retrospective cohort study was conducted of 91 infants and children who presented to local community hospitals with septic shock and required transport to Children’s Hospital of Pittsburgh. Shock reversal (defined by return of normal systolic blood pressure and capillary refill time), resuscitation practice concurrence with ACCM-PALS Guidelines, and hospital mortality were measured. Results. Overall, 26 (29%) patients died. Community physicians successfully achieved shock reversal in 24 (26%) patients at a median time of 75 minutes (when the transport team arrived at the patient’s bedside), which was associated with 96% survival and >9-fold increased odds of survival (9.49 [1.07–83.89]). Each additional hour of persistent shock was associated with >2-fold increased odds of mortality (2.29 [1.19–4.44]). Nonsurvivors, compared with survivors, were treated with more inotropic therapies (dopamine/dobutamine [42% vs 20%] and epinephrine/norepinephrine [42% vs 6%]) but not increased fluid therapy (median volume; 32.9 mL/kg vs 20.0 mL/kg). Resuscitation practice was consistent with ACCM-PALS Guidelines in only 27 (30%) patients; however, when practice was in agreement with guideline recommendations, a lower mortality was observed (8% vs 38%). Conclusions. Early recognition and aggressive resuscitation of pediatric-neonatal septic shock by community physicians can save lives. Educational programs that promote ACCM-PALS recommended rapid, stepwise escalations in fluid as well as inotropic therapies may have value in improving outcomes in these children.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Reference19 articles.

1. Dobkin ED, Lobe TE, Bhatia J, Oldham KT, Traber DL. The study of fecal-Escherichia coli peritonitis-induced septic shock in a neonatal pig model. Circ Shock.1985;16:325–336

2. Natanson C, Danner RL, Reilly JM, et al. Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol.1990;259:H1440–H1447

3. Chung TW, O’Rear EA, Whitsett TL, Hinshaw LB, Smith MA. Survival factors in a canine septic shock model. Circ Shock.1991;33:178–182

4. Hoban LD, Paschall JA, Eckstein J, et al. Awake porcine model of intraperitoneal sepsis and altered oxygen utilization. Circ Shock.1991;34:252–262

5. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med.2001;345:1368–1377

Cited by 510 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3